ONCS insider filings
ONCOSEC MEDICAL Inc — 42 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-02-09. Screen ONCS transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ONCS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — ONCOSEC MEDICAL Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-02-09 | 4 | DelAversano Robert J — VP, Finance | Sale (S): 40 @ $1.37 | EDGAR |
| 2022-11-04 | 4 | DelAversano Robert J — VP, Finance | Sale (S): 283 @ $0.37 | EDGAR |
| 2022-10-12 | 4 | Foster Spahr Stephany — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-08-05 | 4 | DelAversano Robert J — VP, Finance | Sale (S): 284 @ $0.71 | EDGAR |
| 2022-05-06 | 4 | DelAversano Robert J — VP, Finance | Sale (S): 274 @ $0.83 | EDGAR |
| 2022-05-03 | 4 | Arch Robert H. — President and CEO | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4 | DelAversano Robert J — VP, Finance | Sale (S): 409 @ $0.88 | EDGAR |
| 2021-11-03 | 4 | DelAversano Robert J — VP, Finance | Sale (S): 343 @ $1.75 | EDGAR |
| 2021-08-25 | 4 | DALESANDRO MARGARET — Director | Purchase (P): 20,000 @ $1.89 | EDGAR |
| 2021-08-24 | 4 | Zhao Yuhang — Director | Purchase (P): 8,000 @ $1.94 · Purchase (P): 4,000 @ $1.88 | EDGAR |
| 2021-08-03 | 4 | DelAversano Robert J — VP, Finance | Sale (S): 412 @ $2.18 | EDGAR |
| 2021-06-29 | 4 | DEMESA JAMES M — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | DelAversano Robert J — Vice President, Finance | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Leuthner Brian A — Interim CEO | Grant/award (A): 192,000 @ $0 · Sale (S): 13,613 @ $3.16 · Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Smith Kevin Raymond Merrill — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Zhou Chao — Director, 10% owner | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Lyerly Herbert Kim — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Zhao Yuhang — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Ward Robert — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Kim Joon — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | DALESANDRO MARGARET — Director | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | DelAversano Robert J — VP, Finance | Sale (S): 453 @ $4.86 | EDGAR |
| 2021-05-04 | 4 | O'Connor Daniel J. — CEO and President, Director | Sale (S): 3,172 @ $4.86 | EDGAR |
| 2021-04-26 | 4 | China Grand Pharmaceutical & Healthcare Holdings Ltd — 10% owner Grand Decade Developments Ltd — 10% owner Sirtex Medical US Holdings, Inc. — 10% owner | Purchase (P): 1,409,838 @ $3.45 · Purchase (P): 281,968 @ $3.45 | EDGAR |
| 2021-02-23 | 4 | Alpha Holdings, Inc. — Director | Option exercise/expiry (X): 368,250 @ $3.45 · Option exercise/expiry (X): 368,250 (derivative) @ $0.01 | EDGAR |
| 2021-02-17 | 4 | Leuthner Brian A — Chief Operating Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | DelAversano Robert J — Principal Accounting Officer | Grant/award (A): 8,750 @ $0 | EDGAR |
| 2021-02-02 | 4 | O'Connor Daniel J. — CEO and President, Director | Sale (S): 3,413 @ $7.71 | EDGAR |
| 2021-01-27 | 4 | China Grand Pharmaceutical & Healthcare Holdings Ltd — 10% owner Grand Decade Developments Ltd — 10% owner Sirtex Medical US Holdings, Inc. — 10% owner | Purchase (P): 3,389,198 @ $5.45 · Purchase (P): 677,839 @ $5.45 | EDGAR |
| 2020-11-23 | 4 | Alpha Holdings, Inc. — Director | Sale (S): 80,000 @ $4.92 | EDGAR |
| 2020-11-20 | 4 | Alpha Holdings, Inc. — Director | Sale (S): 50,000 @ $5.10 | EDGAR |
| 2020-11-19 | 4 | Alpha Holdings, Inc. — Director | Sale (S): 40,000 @ $5.24 · Sale (S): 10,999 @ $5.24 | EDGAR |
| 2020-11-18 | 4 | Alpha Holdings, Inc. — Director | Sale (S): 40,000 @ $5.41 · Sale (S): 40,000 @ $5.17 | EDGAR |
| 2020-11-03 | 4 | O'Connor Daniel J. — CEO and President, Director | Sale (S): 3,280 @ $3.79 | EDGAR |
| 2020-09-16 | 4 | DEMESA JAMES M — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2020-09-16 | 4 | Ward Robert — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-09-16 | 4 | Lyerly Herbert Kim — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-09-16 | 4 | DALESANDRO MARGARET — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-08-26 | 4 | Foerter Kellie Malloy — Chief Operating Officer | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2020-08-26 | 4 | DelAversano Robert J — Principal Accounting Officer | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2020-08-26 | 4 | O'Connor Daniel J. — CEO and President, Director | Grant/award (A): 152,000 (derivative) @ $0 | EDGAR |
| 2020-08-21 | 4 | China Grand Pharmaceutical & Healthcare Holdings Ltd — 10% owner Grand Decade Developments Ltd — 10% owner Sirtex Medical US Holdings, Inc. — 10% owner | Purchase (P): 1,999,000 @ $3.25 · Purchase (P): 399,800 @ $3.25 | EDGAR |
Recent 8-K events — ONCOSEC MEDICAL Inc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-06-22 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-06-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-06-14 | 8-K | 1.03 — Bankruptcy or Receivership 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-06-02 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-05-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-04-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-04-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-04-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-22 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ONCS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs